関与物質
| 役割 | 名称 | HCID | 仕込み量 |
|---|
| 反応物 | Ammonia | HCID 222 | — |
| 反応物 | Dimethyl Sulfone | HCID 6213 | — |
| 反応物 | Sodium Hydroxide | HCID 14798 | — |
| 反応物 | m-Chloroperbenzoic acid | HCID 70297 | — |
| 反応物 | Bromotrimethylsilane | HCID 76113 | — |
| 反応物 | 1,8-Diazabicyclo(5.4.0)undec-7-ene | HCID 81184 | — |
| 反応物 | 4,6-Bis(methylthio)-1H-pyrazolo[3,4-d]pyrimidine | HCID 223695 | — |
| 反応物 | Di-(2-propyl)-2-chloroethoxymethylphosphonate | HCID 10587339 | — |
| 触媒 | Palladium | HCID 23938 | — |
| 生成物 | 1H-Pyrazolo(3,4-d)pyrimidine | HCID 67499 | — |
反応手順
Di-(2-propyl)-2-chloroethoxymethylphosphonate is reacted with 4,6-bismethylmercapto-pyrazolo[3,4-d]pyrimidine (Tetrahedron, 1967, 23: 891) in the presence of DBU to effect attachment at the pyrazole ring nitrogen(s). Displacement of the 4-methymercapto functionality and concommitant monoester hydrolysis is then effected using aqueous sodium hydroxide. Displacement of the remaining 6-methymercapto group is accomplished (after initial oxidation with m-chloroperbenzoic acid to the intermediate methy sulfone) using methanolic ammonia. Bromination at the 3-position is performed according to the procedure described in J. Med. Chem. 1984, 27: 1026-30. Displacement of the 3-bromo group with Fmoc-protected propargylamine is effected using the palladium(0) catalyst described above. The remaining phosphate ester is then deprotected using bromotrimethylsilane. Pyrophosphorylation, deprotection and dye coupling are then performed as described above to yield the fluorescently labeled PME-G-pp analog (pyrazolo[3,4-d]pyrimidine analog).
情報源と証拠
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| 特許番号 | US06858393B1 |
|---|
| 出典データセット | uspto-grants-2005_02 |
|---|
| ORD ID | ord-f651969384424f18a67bd67ddd5a9807 |
|---|
| 出典メモ | uspto-grants-2005_02 |
|---|